Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial

ECOSPOR IV Investigators

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences